U.S. flag

An official website of the United States government

Medicaid State Plan Amendments

A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.

When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.

Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.

Results

Displaying 41 - 50 of 15692

Pennsylvania

This amendment makes a technical change to update references to a 60-day postpartum period to a 12-month postpartum period in Pennsylvania's Medicaid State Plan. This technical change reflects the coverage individuals are currently and have been receiving since April 1, 2022, when Pennsylvania opted to provide coverage for a 12-month postpartum period.

Approval Date: April 21, 2025
Effective Date: April 1, 2022
Topics: Coverage Program Administration

Rhode Island

This amendment is to modify its Medically Needy Income Levels and confirm the new income standards for its optional state supplement program, beneficiaries of which are eligible for Medicaid under Rhode Island's state plan.

Approval Date: April 18, 2025
Effective Date: January 1, 2025

Kansas

This amendment allows Partial Hospitalization Program (PHP) and Intensive Outpatient Treatment (IOP) of mental health disorders related to Eating Disorder Care.

Approval Date: April 16, 2025
Effective Date: January 1, 2025
Topics: Coverage and Reimbursement

North Carolina

This amendment is to update State Plan assurances in accordance with federally mandated quality reporting requirements for the Child Core Set and the behavioral health quality measures on the Adult Core Set outlined in 42 CFR 431.16 and 437.10 through 437.15.

Approval Date: April 15, 2025
Effective Date: December 31, 2024
Topics: Medicaid and CHIP Program (MACPro) Program Administration

Minnesota

This amendment looks to provide the states' annual inflationary increase to the Adult Crisis Stabilization rate.

Approval Date: April 15, 2025
Effective Date: January 1, 2025

Louisiana

This plan amendment is to extend the temporary rates for intermediate care facilities for individuals with intellectual disabilities (ICF/IID).

Approval Date: April 15, 2025
Effective Date: January 30, 2025

North Dakota

This amendment updates the recipient and provider qualifications for Target Case Management (TCM) for individuals with a behavioral health condition.

Approval Date: April 14, 2025
Effective Date: January 1, 2025
Topics: Coverage Targeted Case Management

Maryland

This amendment is to update State Plan assurances in accordance with federally mandated quality reporting requirements for the Child Core Set and the behavioral health quality measures on the Adult Core Set outlined in 42 CFR 431.16 and 437.10 through 437.15.

Approval Date: April 14, 2025
Effective Date: December 31, 2024
Topics: Medicaid and CHIP Program (MACPro) Program Administration

Montana

This Medicaid State Plan is updated to attest that Montana complies with all requirements for reporting on the Child and Adult Core Sets and will report annually on the measures in the Child Core Set and the behavioral health measures in the Adult Core Set.

Approval Date: April 14, 2025
Effective Date: December 31, 2024
Topics: Medicaid and CHIP Program (MACPro) Program Administration

Kansas

This SPA allows Kansas to enter into Value/Outcomes-Based Agreements with drug manufacturers on a voluntary basis.

Approval Date: April 14, 2025
Effective Date: January 1, 2025
Topics: Value Based Purchasing